ANSES 2019 — Safety of baby diapers (revised opinion, Request No 2017-SA-0019, France)

This revised ANSES opinion is the French food, environmental and occupational health agency’s collective expert appraisal of the safety of single-use baby diapers, prompted by January 2017 popular-press reporting of pesticides, dioxins, furans, PAHs and VOCs in diapers (60 Millions de Consommateurs, 2017). The CES on “Assessment of chemical risks of consumer items and products” conducted a quantitative health risk assessment (QHRA) of chemical exposures via dermal contact for children aged 0-36 months, using analytical results from 23 diaper products tested by SCL (DGCCRF Joint Laboratory Service) and INC (French National Consumer Institute) in 2016, 2017 and 2018. The QHRA concluded that a health risk could not be ruled out for two fragrances (Lyral® / hydroxyisohexyl 3-cyclohexene carboxaldehyde and Lilial® / butylphenyl methylpropional), certain PAHs, PCB-126, and the sums of dioxins, furans and DL-PCBs. Heavy metals were among the substance classes screened for by the INC, but they are not listed among the substances quantified or detected at least once in single-use baby diapers sold in France, are not included in the QHRA, and are not the subject of any of the opinion’s recommendations. This page is ingested as out-of-core-scope regulatory context for the diapers and components product page — it carries the agency-level null finding for heavy metals in French-market diapers and the population-frame exposure parameters (diaper weight, diaper changes per day, body weight, dermal absorption assumptions) that may be reusable for HMI’s future heavy-metals dermal exposure modelling in this product category, alongside the parallel non-metal findings (PAHs, dioxins/furans/DL-PCBs, fragrances) that contextualise the broader chemical-contamination picture in the same product class.

Key numbers

Substance screening panels (p. 4)

• INC screening panel (3 published test sets, 2016/2017/2018; published in 60 Millions de Consommateurs): pesticides, PAHs, dioxins and furans, fragrances and volatile organic compounds (VOCs), heavy metals, nonylphenol, octylphenol, nonylphenol monoethoxylates.
• SCL screening panel (DGCCRF-commissioned, 2017 and 2018): pesticides, PAHs, dioxins, furans and DL-PCBs (“dioxin-like” polychlorinated biphenyls), phthalates, organotins, VOCs, fragrances, azoic dyes.
• Number of products tested: 23 single-use baby diaper products sold on the French market, including best-sellers, retailers’ own-brand products, and “eco-friendly” products.

Substances quantified or detected at least once (p. 4-5)

In shredded whole diapers (solvent extraction):

• VOCs: naphthalene, styrene, toluene, dichlorobenzenes, p-isopropyltoluene, xylenes, chlorobenzene
• Pesticides: hexachlorobenzene, quintozene and its metabolite pentachloroaniline, glyphosate and its metabolite AMPA
• Formaldehyde
• Dioxins, furans, DL-PCBs
• Fragrances: benzyl alcohol, benzyl salicylate, coumarin, hydroxyisohexyl 3-cyclohexene carboxaldehyde (Lyral®), butylphenyl methylpropional (Lilial®), limonene, linalool, alpha-isomethyl ionone

In shredded diaper parts (defined as a component considered separately — elastic bands, inner layer, absorbent pad, etc.; footnote 3, p. 5):

• Dioxins, furans: in outer layer, inner layer and other parts (not the absorbent core)
• PAHs in the elastics: benzo[b]fluoranthene, benzo[a]anthracene, indeno[1,2,3-c,d]pyrene, benzo[g,h,i]perylene

In migration tests with whole and shredded whole diapers using a urine simulant (Colon et al. 2015 simulant composition: urea, creatinine, ammonium citrate, NaCl, KCl, KHSO₄, MgSO₄, KH₂PO₄, KHCO₃ in water; footnote 4, p. 5):

• Dioxins, furans, DL-PCBs
• PAHs
• Formaldehyde

Heavy metals: not listed among substances quantified or detected at least once. Although INC’s screening panel included heavy metals, no metal is named in the detected/quantified inventory on p. 4-5, no metal appears in the QHRA hazard-identification, dose-response, or risk-characterisation sections (p. 5-12), and no metal is the subject of any of the agency’s recommendations (p. 12-14). See Verification notes for the implications.

Exposure parameters used in the QHRA (Table 1, p. 9)

Two scenarios (worst-case and refined), six age strata (0-6, 6-12, 13-18, 19-24, 25-30, 31-36 months):

The most realistic scenario is scenario 2.2 (whole-diaper extraction with urine simulant), because the capacity to extract substances from diaper to urine is measured rather than modelled (no skin-transfer T modelling needed) and only substances actually appearing in pressed urine output are quantified (no reflux ratio R needed).

QHRA findings — Scenario 2.2 (whole diaper + urine simulant, SCL 2018) (Annex 3, p. 20-28)

This is the most realistic scenario per the CES (p. 8). HQ > 1 (threshold effects) or IER > 10⁻⁶ (no-threshold carcinogenic effects) findings for any 0-36 month age class:

• Benzo[a]pyrene: HQ 25.1-66.3 (all ages exceed); IER 1.42e-3 (0-6 mo), 1.82e-3 (6-12), 2.30e-3 (13-18), 2.99e-3 (19-24, maximum), 2.91e-3 (25-30), 2.47e-3 (31-36) — all ages above the 10⁻⁶ acceptable-risk threshold (p. 23)
• Dibenzo[a,h]anthracene: HQ 19.3-51 (all ages exceed); IER 1.09e-3 to 2.30e-3 (all ages above 10⁻⁶) (p. 23)
• Benzo[k]fluoranthene: HQ 2.28-6.03 (all ages exceed); IER 1.29e-4 to 2.72e-4 (all ages above 10⁻⁶) (p. 22)
• Benzo[j]fluoranthene: HQ 2.28-6.03 (all ages exceed); IER 1.29e-4 to 2.72e-4 (p. 22)
• Benzo[b]fluoranthene: HQ 2.36-6.24 (all ages exceed); IER 1.34e-4 to 2.82e-4 (p. 21)
• Cyclopenta[c,d]pyrene: HQ 1.93-5.10 (all ages exceed); IER 1.09e-4 to 2.30e-4 (p. 21)
• Chrysene: HQ 20.22 for 13-18 months only (other ages 0.15-0.41, below 1); IER 8.75e-6 to 1.84e-5 across all ages (above 10⁻⁶) (p. 22)
• PCB-126: HQ 1.57-4.16 (all ages exceed) (p. 27)
• Sum of DL-PCBs (quantified): HQ 1.69-4.46 (all ages exceed) (p. 28)
• Sum of dioxins + furans + DL-PCBs: HQ 1.73-4.58 (all ages exceed) (p. 28)
• Benzo[g,h,i]perylene, 5-methylchrysene, benzo[e]pyrene — Scenario 2.2 HQ < 1 across all ages but IER > 10⁻⁶ for at least one age (per text p. 11 listing the 10 PAHs with IER exceedances).

Scenario 2.2 substances with HQ < 1 and IER ≤ 10⁻⁶ across all ages (no exceedance under the realistic scenario):

• Formaldehyde: HQ 0.34-0.9 across age strata (p. 20).
• Sum of dioxins and furans (quantified): HQ 0.23-0.62 (p. 27).
• Specific dioxin/furan congeners measured in Scenario 2.2 (1,2,3,6,7,8-HxCDD, 1,2,3,4,6,7,8-HpCDD, 2,3,7,8-TCDF, 2,3,4,7,8-PeCDF, 1,2,3,4,7,8-HxCDF, 1,2,3,4,6,7,8-HpCDF, OCDF, 2,3,4,6,7,8-HxCDF) all HQ in the 10⁻³ to 10⁻⁴ range (p. 26-27).

QHRA findings — Scenario 1 (solvent extraction from shredded whole diapers, INC 2017/2018 + SCL 2017) (Annex 3)

Solvent extraction is a worst-case-of-bioavailability scenario; the CES treats Scenario 2.2 as more realistic. Scenario 1 findings flagged:

• Hydroxyisohexyl 3-cyclohexene carboxaldehyde (Lyral®): MOEref/MOE 1.72 (0-6 mo, red); 1.10 (6-12 mo, red); 0.93 (13-18 mo); 0.91 (19-24 mo); 0.82 (25-30 mo); 0.65 (31-36 mo) (p. 25). Two youngest age classes exceed the reference margin.
• Butylphenyl methylpropional (Lilial®): MOEref/MOE 1.72 (0-6 mo, red); 1.10 (6-12 mo, red); 0.93 (13-18 mo); 0.91 (19-24 mo); 0.82 (25-30 mo); 0.65 (31-36 mo) (p. 25). Same exceedance pattern as Lyral®.
• Hexachlorobenzene (pesticide): HQ 3.71e-2 to 9.82e-2 across age strata (all below 1); IER 8.84e-8 (0-6 mo, green) through 2.00e-7 (31-36 mo, orange) — orange in older age classes (between 10⁻⁷ and 10⁻⁶) (p. 20).
• Sum of DL-PCBs (Scenario 1): HQ 8.05e-2 to 0.21 across age strata (0-6 mo orange) (p. 28).
• Sum of dioxins + furans + DL-PCBs (Scenario 1): HQ 0.11 to 0.29 (p. 28).
• Benzo[a]pyrene Scenario 1 (diaper parts shredded, elastics): IER 6.14e-11 to 1.07e-9 (all green) (p. 21).
• VOCs: 1,2,3-trichlorobenzene HQ 4.06e-2 to 0.11 (0-6 mo orange, others green); 1,2,4-trichlorobenzene HQ 9.00e-3 to 2.38e-2 (green) with IER 6.13e-8 to 1.46e-7 (orange in older age classes); 1,3,5-trimethylbenzene HQ 1.56e-2 to 4.13e-2 (all green) (p. 23). None exceed HQ = 1.
• Other fragrances (Scenario 1): Coumarin HQ 0.33-0.86 (all orange); Limonen [sic, Limonene] HQ 0.33-0.86 (all orange); Lyral/Lilial above; alpha-isomethyl ionone MOEref/MOE 6.49e-3 to 0.17 (green to orange); benzyl alcohol HQ 6.49e-3 to 1.72e-2 (green); benzyl salicylate MOEref/MOE 6.49e-3 to 0.17 (orange in 0-6 / 6-12 mo); linalol [sic, linalool] HQ 6.49e-3 to 1.72e-2 (green) (p. 24-25).
• Formaldehyde (Scenario 1): HQ 9.71e-3 to 2.57e-2 across age strata (all green, no exceedance) (p. 20). The much higher Scenario 2.2 HQ (0.34-0.9) is reported in the Scenario 2.2 section above.

QHRA findings — substances explicitly stated to have no exceedance (p. 13, Agency conclusions)

ANSES’s conclusion explicitly lists substances where no exceedance was found across the QHRA:

• Other fragrances (benzyl alcohol, coumarin, limonene, linalool, alpha-isomethyl ionone — none of these substances triggered HQ > 1; coumarin and limonene have orange-band HQs in Scenario 1 for older age classes but none above 1)
• Prohibited pesticides (the majority found are EU-prohibited: lindane and quintozene since 2000, hexachlorobenzene since 2004)
• Glyphosate or its metabolite AMPA
• VOCs (none exceed HQ = 1)
• Formaldehyde (no exceedance — but see Scenario 2.2 HQ 0.34-0.9, orange in younger age classes)

Population frame (p. 3)

• 90% of EU families have used single-use diapers since the 1990s (EDANA 2011)

• 95% of French babies have worn disposable diapers for ~20 years (Group’Hygiène 2015)

• Estimated 3800-4800 disposable diapers used per child before toilet training (varies with toilet-training age 2.5-3 years)
• Diaper-dermatitis prevalence 7-50% (varies with country and hygiene practices), most commonly between 9 and 12 months of age

Methods (brief)

• Expert appraisal framework. French Standard NF X 50-110 “Quality in Expert Appraisals — General Requirements of Competence” (May 2003). Conducted by the CES on “Assessment of chemical risks of consumer items and products” (CES 1, May 2016 - August 2017; subsequently CES 2). Methodological and scientific aspects presented to the CESs between May 2016 and November 2018; collective expert appraisal adopted at the CES meeting of 15 November 2018. Director General sign-off by Dr Roger Genet, 17 January 2019. Conflict-of-interest declarations public on the ANSES website.
• Stakeholder hearings (April-May 2017). UFC (Federal Union of Consumers), companies and trade federations (Love & Green, Procter & Gamble, FCD = Federation of Trade and Retail Companies, SNITEM = National Association of the Medical Technology Industry, Group’Hygiène = French grouping of manufacturers of single-use products for hygiene/health/wiping, EDANA = European Disposables And Nonwovens Association), and the public body French National Consumer Institute (INC).
• Test data sources. INC tests 2016, 2017, 2018 (published in 60 Millions de Consommateurs plus confidential supplements); SCL tests 2017 and 2018 commissioned by DGCCRF; Group’Hygiène 2018 confidential tests. 23 diaper products including best-sellers, retailers’ own-brand, and “eco-friendly”. Three test protocols: (i) solvent extraction from shredded whole diapers or shredded diaper parts; (ii) extraction with urine simulant from shredded whole diapers (SCL 2017); (iii) extraction with urine simulant from whole diapers (SCL 2018).
• Urine simulant composition (Colon et al. 2015; footnote 4, p. 5). Urea, creatinine, ammonium citrate, NaCl, KCl, KHSO₄, MgSO₄, KH₂PO₄, KHCO₃ in water.
• QHRA framework. NRC 1983 four-step framework (hazard identification, dose-response, exposure assessment, risk characterisation). Hazard identification consulted CLP Regulation harmonised classifications (EC No 1272/2008), IARC carcinogenicity classifications, and endocrine-disruption databases (European Commission BKH 2000, 2002; DHI 2007; US EPA; Illinois EPA; TEDX; SIN List). TRVs prioritised by chronic-duration, repeated and/or long-term low-to-moderate-dose criteria, focused initially on dermal route but extended to oral route where dermal TRVs were unavailable (no dermal TRVs were found for any substance in this appraisal). For PAHs and dioxins/furans/DL-PCBs, only TRVs for the reference congener (benzo[a]pyrene for PAHs; 2,3,7,8-TCDD for dioxins/furans/DL-PCBs) were identified; other congeners assessed by toxic equivalency factors (TEFs).
• Daily exposure dose (DED) formulae (p. 7-8).
  • Scenario 1 (solvent extraction): DED = (C_shredded-material × W × F × T × Abs) / BW
  • Scenario 2.1 (urine simulant in shredded diaper): DED = (C_shredded-material-simulant × W × F × R × Abs) / BW
  • Scenario 2.2 (urine simulant in whole diaper): DED = (C_diaper-simulant × W × F × Abs) / BW
• Risk characterisation. HQ = DED / TRV (threshold effects, traffic-light thresholds < 0.1, 0.1-1, > 1); IER for no-threshold (carcinogenic) effects (< 10⁻⁷, 10⁻⁷-10⁻⁶, > 10⁻⁶ acceptable risk threshold); MOE = critical dose / DED where no TRV available.
• Worst-case-first approach. Worst-case scenario applied to all substances first; refined scenario applied only where worst-case exceeded TRV.

Implications

• Certification (HMTc): This opinion provides no heavy-metal occurrence data and contributes nothing directly to the HMTc 10-analyte panel (Pb, tAs, Cd, MeHg, tHg, iAs, Ni, Al, Cr-VI, Sn). For Category 9 Row 7 (diapers and diaper components), it is one of the rare national-agency-level data points and carries the agency-level null finding for heavy metals in French-market diapers — useful as regulatory-context evidence that a competent national authority screened heavy metals in this product category and did not surface any metal as a risk-relevant finding requiring further QHRA. The opinion’s population-frame parameters (24-45 g per diaper across age strata; 4.7-7.98 diaper changes per day across age strata; 3.9-11.4 kg body weight across age strata; 7% skin transfer per Odio et al. 2000; 1.32% reflux ratio per Dey et al. 2016; 100% dermal absorption retained because diaper dermatitis cannot be excluded) are directly reusable in any future HMI dermal-exposure model for metals in disposable diapers — the same DED framework applies regardless of analyte class.
• Courses: Useful as a reference for any HMTc Cat 9 module covering national-agency regulatory positioning on diaper safety, the structure of a NRC-1983-style QHRA applied to a dermal-contact infant product, and the worst-case → refined two-stage approach to triaging substances by exceedance.
• App: Not directly applicable to the heavy-metals consumer app. Useful as background for a future app explainer on what the French national agency has and has not assessed in the diaper category.
• Microbiome: Not addressed.

Wiki pages this source may touch

• diapers-and-components — primary routing destination (HMTc Cat 9 Row 7 scaffold). National-agency QHRA reference for the product class; null finding for heavy metals; non-metal context (PAHs, dioxins/furans/DL-PCBs, fragrances) for cross-contaminant framing.

Verification notes

• Heavy metals null finding — strict reading. The INC screening panel explicitly included “heavy metals” (p. 4, first bullet under “Chemicals identified in baby diapers / Chemical contamination”). The subsequent inventory of “substances quantified or detected at least once via these tests in single-use baby diapers sold in France” (p. 4-5) lists VOCs, pesticides, formaldehyde, dioxins/furans/DL-PCBs, fragrances, and PAHs (in elastics), but does NOT name any heavy metal. The QHRA hazard-identification, TRV synthesis (Annex 2, p. 18-19), exposure-assessment (p. 8), risk-characterisation (Annex 3, p. 20-28), and recommendations (p. 12-14, 13-14) make no mention of any metal. The opinion does not state whether the INC heavy-metal screen returned non-detects across the panel or whether specific metals were detected but at levels deemed not risk-relevant. The opinion also does not disclose which specific metals were on the INC screening panel. The page records metals: [] to reflect that no specific metal is named at any point in the document; readers needing per-metal screening detail should consult the underlying INC 2016/2017/2018 publications (60 Millions de Consommateurs reports) directly. The opinion text itself does not constitute occurrence evidence for any specific metal in this product class.
• Brand firewall compliance — Part 12 strict reading. The opinion names commercial entities in two contexts: (i) the stakeholder-hearing list (UFC, Love & Green, Procter & Gamble, FCD, SNITEM, Group’Hygiène, EDANA, INC) on p. 2 documents the regulatory expert-appraisal process and falls under Part 12 Exception 1 (regulatory-event subject — the brands were heard by the agency, not measured for contamination); (ii) the fragrance trade names “Lyral®” and “Lilial®” are scientific identifiers for hydroxyisohexyl 3-cyclohexene carboxaldehyde and butylphenyl methylpropional respectively, not consumer-product brands, and are retained per Part 12 Exception 2 (scientific-method vendor/material names). The opinion does NOT name any specific diaper product brand alongside any specific contamination value, so no brand-firewall scrubbing was needed at the per-sample level. The phrase “best-selling commercial products on the French market” describes the sampling frame without naming brands.
• Wiki/HMTc firewall — Part 2. This page reports what the ANSES opinion concludes about chemical risks in baby diapers under the agency’s QHRA framework. It does not extrapolate to HMTc thresholds, does not advocate for a particular Cat 9 Row 7 limit, and does not synthesise with other diaper sources (the absence of heavy-metal data here is reported as the opinion reports it; cross-source synthesis with smajgl2015-tin-baby-diapers-croatia, nyamukamba2023-south-africa-diapers-metals-formaldehyde and lai2025-infant-diaper-phthalate-dna-oxidation is left to the Part 9 synthesis pass).
• Document identity. ANSES Opinion Request No 2017-SA-0019, dated 17 January 2019 (Maisons-Alfort), signed Dr Roger Genet. Footnote 1 (p. 1): “Cancels and replaces the Opinion of 6 December 2018 (see change history in Annex 1).” Annex 1 (p. 16) lists the 08/01/2019 modifications: typology/layout/spelling fixes; Table 1 acronym additions and removal of “100% for scenario 1” regarding reflux ratio in refined scenario; wording change on p. 11 from “exceedances of the health threshold related to non-threshold effects (carcinogenic effects)” to “cases in which the risk indicator (no-threshold carcinogenic effects) was exceeded”; footnote 16 addition; ALARA definition added in footnote on p. 14. This page ingests the 17 January 2019 revised English-translation version. The French-language original prevails in case of discrepancy (footnote, p. 1: “Its opinions are published on its website. This opinion is a translation of the original French version. In the event of any discrepancy or ambiguity the French language text dated 17 January 2019 shall prevail.”).
• No DOI. ANSES Opinions are not DOI-assigned at issuance. Frontmatter doi: null is correct. Identity is established via the ANSES request identifier 2017-SA-0019 and the publication date.
• Sample size attribution. The number 23 (single-use baby diaper products tested across SCL and INC programmes) appears on p. 13 of the Agency conclusions (“Analyses and tests involving 23 single-use baby diaper products available on the market were undertaken by the Joint Laboratories Service (SCL) and the French National Consumer Institute (INC)”). The opinion does not break down which of the 23 products were tested by which lab in which year.
• Population frame source. The 3800-4800 diapers/child estimate is attributed to Group’Hygiène 2015 (p. 3). The 95% French diaper-wearing rate and 20-year duration are attributed to Group’Hygiène 2015. The 90% EU rate since the 1990s is attributed to EDANA 2011. The 7-50% dermatitis prevalence is sourced to Klunk 2014 (p. 3).
• TRV provenance (Annex 2, p. 18-19). TRVs used in QHRA cited to RIVM 2001 (1,2,3-trichlorobenzene), ATSDR 2014 (1,2,4-trichlorobenzene), US EPA 2016 (1,3,5-trimethylbenzene), ATSDR 2015 (hexachlorobenzene threshold), OEHHA 2011 (hexachlorobenzene no-threshold), US EPA 2012 (2,3,7,8-TCDD for dioxins/furans/DL-PCB), US EPA 2017 (benzo[a]pyrene for PAH, both threshold and no-threshold), OEHHA 1999 (1,2,4-trichlorobenzene no-threshold), OMS-IPCS 2005 (formaldehyde), EFSA 2008-2012 (coumarin, limonene), JECFA 1998 (linalool), SCCS 2011-2016 (Lyral and Lilial NOAELs), Belsito et al. 2007 (alpha-isomethyl ionone NOAEL), US EPA 2010 (benzyl salicylate NOAEL), EFSA 2011 (benzyl alcohol).
• Footnote 7 — endocrine-disruption databases consulted (p. 6). “Classifications of the European Commission (BKH, 2000 and 2002; DHI, 2007), the US EPA and the Illinois EPA and inclusion on the TEDX (The Endocrine Disruption Exchange Inc) and SIN (Substitute It Now) lists” — these classifications “were not analysed by ANSES as part of this expert appraisal” per footnote 16 (added in the 08/01/2019 revision).
• Recommendation on chlorinated dioxin/furan/DL-PCB congener limits. The CES recommends setting a maximum concentration “not to be exceeded for each chlorinated dioxin and furan and DL-PCB congener that would be of the same order of magnitude as the limit of quantification. Initially, the lowest LQ used in this expert appraisal (around 0.02 ng/kg) could be proposed. This value is not a health threshold” (p. 13). This is a precautionary regulatory anchor at LQ, not a health-based threshold.
• Routing destination check. products/diapers-and-components exists as wiki/products/diapers-and-components.md (HMTc Cat 9 Row 7 scaffold, consistent with the routing destination used by the three sibling diaper sources nyamukamba2023-south-africa-diapers-metals-formaldehyde, lai2025-infant-diaper-phthalate-dna-oxidation, and smajgl2015-tin-baby-diapers-croatia).
• Audit subagent (2026-06-01, fresh-context general-purpose agent) — three findings applied.
  • ❌ Finding 1 (verified correct): Benzo[a]pyrene Scenario 2.2 IER range was stated as “2.47e-3 to 1.42e-3”, which used only the first and last age-stratum values and missed the non-monotonic peak. Verified against PDF Annex 3 p. 23: the six age-stratum IER values are 1.42e-3 (0-6 mo), 1.82e-3 (6-12), 2.30e-3 (13-18), 2.99e-3 (19-24, true maximum), 2.91e-3 (25-30), 2.47e-3 (31-36). Corrected to list per-age values explicitly so readers see the 19-24 month peak.
  • ❌ Finding 2 (verified correct): Formaldehyde HQ range was stated as “9.71e-3 to 0.9 in scenario 2.2”, which conflated the Scenario 1 31-36-month value (9.71e-3) with the Scenario 2.2 range. Verified against PDF Annex 3 p. 20: Scenario 2.2 HQ is 0.34-0.9; Scenario 1 HQ is 9.71e-3 to 2.57e-2. Corrected by splitting into the Scenario 2.2 and Scenario 1 sections, each with its own range.
  • ⚠️ Finding 3 (verified correct): The original “Scenario 2.2” findings section grouped Lyral®/Lilial® MOEs and VOC HQs under a Scenario 2.2 banner. Verified against PDF Annex 3: Lyral/Lilial MOE values appear only in the Scenario 1 column (p. 25); VOC HQs appear only in the Scenario 1 column (p. 23); other fragrances appear only in the Scenario 1 column (p. 24). Restructured into separate Scenario 2.2 and Scenario 1 findings subsections per audit recommendation. Section now distinguishes which scenario each finding belongs to and adds the IER columns for the Scenario 2.2 PAHs that the original section omitted.

Ingest log

• 2026-06-01 fresh ingest (Claude Opus 4.7, autonomous v2.0 manual-fetch skill). NEW path. Three identity checks against wiki/sources/ returned no hits: no DOI (ANSES opinions are not DOI-assigned); raw_handle MFK_07-conso2017sa0019en-2019 not present; cite-key stem anses2019 not present. PDF SHA-256 602c3dd29a079409d12d5fdf3e38d91f3aec58fea531648b9161d52906e3327a. Folder: raw/Manual Fetch Kimi /May 21 Kimi_Agent_Download Corruption Issue/_extracted_infantcontact_03_Diapers/03_Diapers/. Source is a national-agency regulatory opinion (32 pp.); metals: [] reflects that the opinion does not name or quantify any specific heavy metal — heavy metals were on INC’s screening panel but are absent from the inventory of detected/quantified substances, the QHRA, and the recommendations. Routed to [[products/diapers-and-components]] per matrices: [diaper], following the lai2025 precedent for ingesting diaper papers without metal occurrence data as out-of-core-scope regulatory/methodology context.

Page history

The five most recent substantive edits to this page. The full version history lives in git; when DOI minting comes online (see schema docs), each entry below will also link to a version-pinned DataCite DOI.